Yukio NAKAMURA et al. 2018. Tofacitinib Versus Non-Tumor Necrosis Factor Biologics for Patients With Active Rheumatoid Arthritis. Archives of Rheumatology. 33, 2 (Jun. 2018), 154–159. DOI:https://doi.org/10.5606/ArchRheumatol.2018.6366.